Novavax Inc: Highlights
Financial data in U.S. dollars
| Financial Highlights |
|---|
| Sales |
314000.00 |
| Income |
-37.79 Mil |
| Net Profit Margin |
NA |
| Return on Equity |
-70.68% |
| Debt/Equity Ratio |
0.10 |
|
| Revenue/Share |
0.00 |
| Earnings/Share |
-0.50 |
| Book Value/Share |
0.67 |
| Dividend Rate |
0.00 |
| Payout Ratio |
NA |
|
| Revenue - Quarterly Results (in Millions) |
|---|
| | FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | 0.0 | 0.5 | 0.5 |
| 2nd Qtr | 0.0 | 0.3 | -0.2 |
| 3rd Qtr | NA | 0.2 | 0.8 |
| 4th Qtr | NA | 0.1 | 0.4 |
| Total | 0.1 | 1.1 | 1.4 |
| Earnings Per Share - Quarterly Results |
|---|
| | FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | -$0.12 | -$0.13 | -$0.14 |
| 2nd Qtr | -$0.10 | -$0.15 | -$0.13 |
| 3rd Qtr | NA | -$0.12 | -$0.15 |
| 4th Qtr | NA | -$0.16 | -$0.15 |
| Total | -$0.22 | -$0.56 | -$0.57 |
| Qtr. over Qtr. EPS Growth Rate |
| FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | 25% | 13% | --- |
| 2nd Qtr | 17% | -15% | 7% |
| 3rd Qtr | NA | 20% | -15% |
| 4th Qtr | NA | -33% | 0% |
| Yr. over Yr. EPS Growth Rate |
| FY (12/09) | FY (12/08) |
|---|
| 1st Qtr | 8% | 7% |
| 2nd Qtr | 33% | -15% |
| 3rd Qtr | NA | 20% |
| 4th Qtr | NA | -7% |
advertisement
Recent News